Animal model development and initial efficacy testing
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,282,916
Award facts
- Opportunity
-
- RFPNIAIDDAITNIHAI2014005 Solicitation number
- Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services Award Notice · Posted Aug 18, 2014
- Contract value 100% obligated
- $9,282,915.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$91,436 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $610,020 | |
| Change Order | $578,102 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $2,870,980 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $5,315,249 |
Show all 11
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 30, 2019, with a ceiling value of $9,282,915.50 for animal model development and initial efficacy testing and radiation/nuclear medical countermeasure product development support services.
Place of performance is Menlo Park, CA. The order operates under cost-plus-fixed-fee pricing and was obligated to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) for closure on September 30, 2026.
Service Contract Inventory reporting across FY2021 and FY2022 shows declining labor volume: FY2021 invoiced $3.9 million across 6.5 FTEs and 13,429 contractor hours at a derived rate of $293.70/hr; FY2022 invoiced $1.3 million across 0.4 FTEs and 917 contractor hours at $1,422.46/hr, reflecting a shift toward higher-rate subcontracted delivery. In FY2022, one subcontractor accounted for 93 percent of contractor hours.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $9,282,916 on 75N93019F00131.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201500013I, an indefinite delivery contract.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award